Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Athira Pharma Inc ATHA

Healthcare
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline consists of both blood brain barrier permeable and peripherally restricted drug candidates for the central nervous system (CNS), peripheral nervous system, and other indications. Its lead candidate... see more

Recent & Breaking News (NDAQ:ATHA)

CLASS ACTION UPDATE for ATHA, DKNG and COIN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire August 19, 2021

TUESDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile August 19, 2021

SHAREHOLDER ALERT: ATHA ATVI LIVE: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire August 19, 2021

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)

PR Newswire August 18, 2021

LAWSUITS FILED AGAINST ATHA, AHCO and ATVI - Jakubowitz Law Pursues Shareholders Claims

Accesswire August 18, 2021

ATHA 6-DAY DEADLINE ALERT: Hagens Berman Encourages Athira Pharma (ATHA) Investors with Losses to Contact Firm's Attorneys Now, Securities Class Action Pending

Newsfile August 18, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ATHA, BZ and DIDI

Accesswire August 18, 2021

TUESDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Athira Pharma, Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile August 18, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATHA, BLCT and PHG

Accesswire August 17, 2021

Athira Deadline Alert

Newsfile August 17, 2021

CLASS ACTION UPDATE for ATHA, AHCO and LIVE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire August 17, 2021

Final Deadline Approaching on August 24, 2021: Kessler Topaz Meltzer & Check, LLP Reminds Athira Pharma, Inc. Investors of Class Action Lawsuit Deadline

Newsfile August 17, 2021

SHAREHOLDER ALERT: SRAC ATHA ITRM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire August 17, 2021

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire August 17, 2021

Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update

GlobeNewswire August 16, 2021

FRIDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile August 16, 2021

CLASS ACTION UPDATE for JRVR, ATHA and REKR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire August 16, 2021

Wolf Popper LLP Reminds Athira Pharma, Inc. (ATHA) Investors of August 24, 2021 Lead Plaintiff Filing Deadline

Newsfile August 16, 2021

Lawsuits Filed Against ATHA, BZ and CRMD - Jakubowitz Law Pursues Shareholders Claims

Accesswire August 16, 2021

Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc.

Newsfile August 15, 2021